Pfizer and BioNTech said that they have submitted its data to European Medicines Agency (EMA) which support use of their COVID-19 vaccine in young kids aged between five and less than 12 years.


New York: Pfizer and BioNTech said that they have submitted its data to European Medicines Agency (EMA) which support use of their COVID-19 vaccine in young kids aged between five and less than 12 years.
Pfizer vaccine has been approved for use in children over 12 years old in United States (US) and The European Union (EU)—excluding children less than 12.
In October, the companies asked U.S. regulators to also allow emergency use authorization of the vaccine in young children, U.S. Food and Drug Administration’s advisory panel is likely to meet next month to review the data.
As per reports, children are less vulnerable to severe novel coronavirus, but still they can spread the virus to others, including susceptible populations more at danger of severe illness.
On September 20, the companies claimed that the Pfizer and BioNTech vaccine has been shown strong immune response in five to eleven year olds in a clinical trial of 2,268-participant.

Canva adds an AI ‘off’ button
- 19 hours ago

EU proposes tax on Big Tech to boost budget
- 11 hours ago

Listen to this: Armand Hammer’s Snakes & Ladders
- 4 hours ago

Pakistan-Indonesia joint exercise 'Elang Strike-III' concludes at Pabbi
- 17 hours ago

FBI, US Agriculture Department breached by hackers: reports
- 14 hours ago

Satya Nadella says he’s AGI-pilled now
- 4 hours ago

Oh, Elon Musk is ‘moderate’ now, is he?
- 19 hours ago

PCB announces central contracts for 38 men's cricketers with key players absent
- 16 hours ago

Teachers are reeling from an existential crisis. You’re probably feeling it too.
- 17 hours ago
COLTS release QB Daniel Jones...
- 3 hours ago

Zelensky reaffirms Ukraine's wish to join NATO
- 11 hours ago

How Uruguay built a national care system from the ground up
- 17 hours ago
















